American Vietnamese Biotech (HSTC:AMV) Net Margin %: 0.00% (As of . 20)


What is American Vietnamese Biotech Net Margin %?

American Vietnamese Biotech HSTC:AMV Net Margin % is 0.00% as of . 20.

Net margin is calculated as Net Income divided by its Revenue. American Vietnamese Biotech's Net Income for the three months ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, American Vietnamese Biotech's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for American Vietnamese Biotech's Net Margin % or its related term are showing as below:


HSTC:AMV's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.33
* Ranked among companies with meaningful Net Margin % only.

American Vietnamese Biotech  (HSTC:AMV) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

American Vietnamese Biotech Net Margin % Related Terms

American Vietnamese Biotech Net Margin % Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Net Margin % Chart

American Vietnamese Biotech Annual Data
Trend
Net Margin %

American Vietnamese Biotech Quarterly Data
Net Margin %

HSTC:AMV vs HSTC, STLT, CTBO: Net Margin % Comparison

For the Biotechnology subindustry, American Vietnamese Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Vietnamese Biotech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Net Margin % falls into.


American Vietnamese Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

American Vietnamese Biotech's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

American Vietnamese Biotech's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
American Vietnamese Biotech (HSTC:AMV) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's Net Margin % too high?
American Vietnamese Biotech's current Net Margin % is 0.00%.
How does American Vietnamese Biotech's Net Margin % compare to HSTC and STLT?
American Vietnamese Biotech's Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.